{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:30:33Z","timestamp":1782736233293,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["141\/19"],"award-info":[{"award-number":["141\/19"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["15\/19"],"award-info":[{"award-number":["15\/19"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["AZV VES 2020 VFN"],"award-info":[{"award-number":["AZV VES 2020 VFN"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NU20-04-00088"],"award-info":[{"award-number":["NU20-04-00088"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016366","name":"V\u0161eobecn\u00e1 Fakultn\u00ed Nemocnice v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.sleep.2023.11.039","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:39:33Z","timestamp":1701365973000},"page":"220-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Investigation of anti-neuronal antibodies and disparity in central hypersomnias"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-971X","authenticated-orcid":false,"given":"Petra","family":"Prochazkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Sonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Roubalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Jezkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Nevsimalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Buskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radana","family":"Merkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Dvorakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Prihodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Dostalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Tlaskalova-Hogenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2023.11.039_bib1","series-title":"Neuroendocrine-immune system interactions. Masterclass in neuroendocrinology","first-page":"187","article-title":"Neuropeptide binding autoantibodies regulating neuroendocrine communications","author":"Fetissov","year":"2023"},{"key":"10.1016\/j.sleep.2023.11.039_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0079-6123(08)61178-4","article-title":"Antibodies to neuropeptides as alternatives for peptide receptor antagonists in studies on the physiological actions of neuropeptides","volume":"92","author":"van Oers","year":"1992","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.sleep.2023.11.039_bib3","series-title":"Infection and autoimmunity","author":"Shoenfeld","year":"2015"},{"key":"10.1016\/j.sleep.2023.11.039_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.613983","article-title":"Current aspects of the role of autoantibodies directed against appetite-regulating hormones and the gut microbiome in eating disorders","volume":"12","author":"Smitka","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.sleep.2023.11.039_bib5","first-page":"1","article-title":"Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept","volume":"296","author":"Oldstone","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.sleep.2023.11.039_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fimmu.2017.00598","article-title":"Leaky gut as a danger signal for autoimmune diseases","volume":"8","author":"Mu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.sleep.2023.11.039_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sleep.2023.11.039_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fncel.2015.00392","article-title":"Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders","volume":"9","author":"Kelly","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.sleep.2023.11.039_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.sleep.2023.11.039_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.sleep.2023.11.039_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad005","article-title":"What triggered narcolepsy: H1N1 vaccination, virus, or both? Important lessons learned from China","volume":"46","author":"Gool","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.sleep.2022.11.036","article-title":"Changed epidemiology of narcolepsy before, during, and after the 2009 H1N1 pandemic: a nationwide narcolepsy surveillance network study in mainland China, 1990-2017","author":"Wang","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013320","article-title":"Increased immune complexes of hypocretin autoantibodies in narcolepsy","volume":"5","author":"Deloumeau","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.sleep.2023.11.039_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/sleep\/29.5.633","article-title":"Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy","volume":"29","author":"Tanaka","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw056","article-title":"Antibodies against hypocretin receptor 2 are rare in narcolepsy","volume":"40","author":"Giannoccaro","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sleep.2020.08.001","article-title":"Conventional autoantibodies against brain antigens are not routinely detectable in serum and CSF of narcolepsy type 1 and 2 patients","volume":"75","author":"Dietmann","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.11.039_bib19","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2023.11.039_bib20","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1038\/s41598-021-87481-8","article-title":"T cell reactivity to regulatory factor X4 in type 1 narcolepsy","volume":"11","author":"Luo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2023.11.039_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw070","article-title":"CD4+ T-cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1","volume":"40","author":"Ramberger","year":"2017","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib22","series-title":"International classification of sleep disorders","year":"2014"},{"key":"10.1016\/j.sleep.2023.11.039_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-5-12","article-title":"Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales","volume":"5","author":"Hjollund","year":"2007","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.sleep.2023.11.039_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10608-015-9686-4","article-title":"Development and validation of the sleep inertia questionnaire (SIQ) and assessment of sleep inertia in analogue and clinical depression","volume":"39","author":"Kanady","year":"2015","journal-title":"Cognit Ther Res"},{"key":"10.1016\/j.sleep.2023.11.039_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.sleep.2023.11.039_bib27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0895-4356(98)00081-X","article-title":"Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) Project","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sleep.2023.11.039_bib28","first-page":"63","article-title":"Narcolepsy severity scale and its psychometric properties in patients with narcolepsy type 1 in the Czech Republic","volume":"86","author":"Buskova","year":"2023","journal-title":"Ces Slov Neurol Neurochir"},{"key":"10.1016\/j.sleep.2023.11.039_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0000000000003787","article-title":"Measurement of narcolepsy symptoms: the narcolepsy severity scale","volume":"88","author":"Dauvilliers","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2023.11.039_bib30","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1212\/WNL.0000000000007264","article-title":"Measurement of symptoms in idiopathic hypersomnia: the idiopathic hypersomnia severity scale","volume":"92","author":"Dauvilliers","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2023.11.039_bib31","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.sleep.2023.11.039_bib32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.biocel.2013.09.014","article-title":"The molecular basis for the immunomodulatory activities of unconjugated bilirubin","volume":"45","author":"Jangi","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.sleep.2023.11.039_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3892\/mmr.2017.6825","article-title":"Unconjugated bilirubin ameliorates the inflammation and digestive protease increase in TNBS-induced colitis","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.sleep.2023.11.039_bib34","first-page":"179","article-title":"Low serum bilirubin levels associated with subclinical atherosclerosis in patients with obstructive sleep apnea","volume":"10","author":"Duman","year":"2018","journal-title":"Interv Med Appl Sci"},{"key":"10.1016\/j.sleep.2023.11.039_bib35","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.joms.2019.05.023","article-title":"Severe sleep apnea associated with increased systemic inflammation and decreased serum bilirubin","volume":"77","author":"Friedlander","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.sleep.2023.11.039_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/nu14050921","article-title":"Effects of creatine supplementation on brain function and health","volume":"14","author":"Forbes","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.sleep.2023.11.039_bib37","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ccr3.2873","article-title":"Narcolepsy, depression, and severe flushing in an obese man","volume":"8","author":"Biobaku","year":"2020","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.sleep.2023.11.039_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1389-9457(00)00031-9","article-title":"Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy","volume":"1","author":"Mitler","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.11.039_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sleep.2023.11.039_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12111491","article-title":"Central disorders of hypersomnolence: association with fatigue, depression and sleep inertia prevailing in women","volume":"12","author":"Nevsimalova","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.sleep.2023.11.039_bib41","series-title":"International classification of sleep disorders","year":"2014"},{"key":"10.1016\/j.sleep.2023.11.039_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101306","article-title":"Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts","volume":"52","author":"Lammers","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.039_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.sleep.2014.09.016","article-title":"Narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: a cluster analysis","volume":"16","author":"Sonka","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2023.11.039_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.039_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.sleep.2023.11.039_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","article-title":"Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy","volume":"33","author":"Kawashima","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","article-title":"Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy","volume":"33","author":"Toyoda","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.11.039_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jim.2019.01.004","article-title":"Reducing the risk of misdiagnosis of indirect ELISA by normalizing serum-specific background noise: the example of detecting anti-FGFR3 autoantibodies","volume":"466","author":"Moritz","year":"2019","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.sleep.2023.11.039_bib49","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/tp.2014.98","article-title":"Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide alpha-MSH, at the origin of eating disorders","volume":"4","author":"Tennoune","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.sleep.2023.11.039_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fnins.2015.00475","article-title":"Melanin-concentrating hormone (MCH): role in REM sleep and depression","volume":"9","author":"Torterolo","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.sleep.2023.11.039_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smrv.2012.10.002","article-title":"Melanin-concentrating hormone control of sleep-wake behavior","volume":"17","author":"Monti","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.039_bib52","first-page":"244","article-title":"Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep","volume":"8","author":"Konadhode","year":"2014","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.sleep.2023.11.039_bib53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2023.11.039_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.smrv.2009.09.001","article-title":"Neuropeptide Y and sleep","volume":"14","author":"Dyzma","year":"2010","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.11.039_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neures.2005.11.006","article-title":"Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat","volume":"54","author":"Akanmu","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.sleep.2023.11.039_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2015.04.008","article-title":"Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination","volume":"283","author":"van der Heide","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.sleep.2023.11.039_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12890-018-0647-z","article-title":"The level of lipopolysaccharide-binding protein is elevated in adult patients with obstructive sleep apnea","volume":"18","author":"Kong","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.sleep.2023.11.039_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/08869634.2020.1839721","article-title":"Elevated serum calprotectin as an inflammatory marker in obstructive sleep apnea","volume":"41","author":"Yurtsever Kum","year":"2023","journal-title":"Cranio"},{"key":"10.1016\/j.sleep.2023.11.039_bib59","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1074\/jbc.M117.796631","article-title":"Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKK\u03f5-IRF3 axis activation","volume":"293","author":"Tsukamoto","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sleep.2023.11.039_bib60","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.172.7.4470","article-title":"CD14 is an acute-phase protein","volume":"172","author":"Bas","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.sleep.2023.11.039_bib61","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1073\/pnas.90.7.2744","article-title":"Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14","volume":"90","author":"Pugin","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2023.11.039_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246073","article-title":"Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: veterans Aging Cohort Study","volume":"16","author":"Polanka","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.sleep.2023.11.039_bib63","doi-asserted-by":"crossref","first-page":"24309","DOI":"10.1074\/jbc.273.38.24309","article-title":"Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.sleep.2023.11.039_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474124.2014.869476","article-title":"The use of fecal calprotectin as a biomarker in gastrointestinal disease","volume":"8","author":"Burri","year":"2014","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.sleep.2023.11.039_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030857","article-title":"Body mass index and calprotectin blood level correlation in healthy children: an individual patient data meta-analysis","volume":"9","author":"Grand","year":"2020","journal-title":"J Clin Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723004653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:48:47Z","timestamp":1761407327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723004653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":65,"alternative-id":["S1389945723004653"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.039","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of anti-neuronal antibodies and disparity in central hypersomnias","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}